Haleos Labs Limited (NSE:HALEOSLABS)
1,596.30
+197.50 (14.12%)
Nov 12, 2026, 3:29 PM IST
Haleos Labs Revenue
Haleos Labs had revenue of 914.60M INR in the quarter ending September 30, 2026, with 12.40% growth. This brings the company's total for the last twelve months to 3.35B, down -0.90% year-over-year. In the fiscal year ending March 31, 2026, Haleos Labs had annual revenue of 3.34B, down -3.17%. That makes Haleos Labs the 30,267th largest company in the world by revenue and 2,133rd in India.
Revenue (ttm)
3.35B
Revenue Growth
-0.90%
P/S Ratio
1.44
Revenue / Employee
5.48M
Employees
611
Market Cap
4.83B
Revenue by Geography
- India 2.06B 61.7%
- Exports 1.25B 37.5%
- Deemed Exports 16.22M 0.5%
- Unallocated 9.15M 0.3%
Fiscal year ended Mar 31, 2026 See the full Haleos Labs breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 3.34B | -109.29M | -3.17% |
| Mar 31, 2025 | 3.45B | 387.65M | 12.67% |
| Mar 31, 2024 | 3.06B | -96.02M | -3.04% |
| Mar 31, 2023 | 3.16B | -345.11M | -9.86% |
| Mar 31, 2022 | 3.50B | 844.79M | 31.81% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Biocon | 174.15B |
| Dishman Carbogen Amcis | 29.01B |
| Anthem Biosciences | 20.50B |
| OneSource Specialty Pharma | 16.86B |
| Concord Biotech | 11.70B |
| Blue Jet Healthcare | 11.05B |
| Supriya Lifescience | 8.79B |
| Zota Health Care | 6.79B |